2.6 Review

StrawberryIce · 2026-02-06T08:53:32+00:00

The index exhibits a V-shaped recovery, with short-term focus on high-recognition leading stocks, and market sentiment gradually strengthening. All major indices turn red across the board, with decreasing trading volume. Leading stocks include Hengdian Film & Television and Yaowang Technology, avoiding photovoltaic and high-level thematic stocks. The trading strategy is to buy leading stocks on dips, enter and exit quickly, with cautious position management. Tomorrow, pay attention to trading volume and northbound funds, and remain alert to market risks.

StrawberryIce

2026-02-06 08:53:32

Abstract generation in progress

The V-shaped recovery of the index, weak sentiment turning strong, short-term focus on high-recognition leading stocks, with bears concentrated on high-level themes and photovoltaics. Before the holiday, the strategy is centered on reduced volume rotation and group recognition.

I. Index and Sentiment

• Index: The three major indices opened lower and then rose across the board to turn red, with the Shanghai Composite above 4080, and the Shenzhen Component/ChiNext up about 0.65%, supported by strong 4030 levels.

• Volume: Half-day trading volume reached 1.38 trillion yuan (a decrease of 64.2 billion), with slight volume increase in the afternoon, showing clear signs of rotation with reduced volume.

• Sentiment: Over 3,800 stocks rose, with increasing number of limit-up stocks. High-level rebound and low-level catch-up run parallel, and group recognition remains key.

II. Leading Stock List (Short-term Core)

Overall Sentiment Leaders: Hengdian World Studios (six days of limit-up, Spring Festival blockbusters), Remote Vision Technology (limit-up in seconds, AI e-commerce).
Sector Leaders

• Chemicals: Cangzhou Dahua, Lily Flower, Baichuan Shares (dyes/raw materials, collectively hitting the limit).

• Commercial Aerospace: Julli Sui, GCL System Integration, China Super Holdings (offshore recovery/solar, leading the rotation).

• Traditional Chinese Medicine: Teyi Pharmaceutical, Hansen Pharmaceutical (policy benefits, limit-up).

• Tungsten Metals: Xianglu Tungsten, Zhangyuan Tungsten (leading the non-ferrous sector).

• AI Applications: Zhejiang Wenhulian, Blue Cursor (recovery, Zhejiang Wenhulian as a weather vane).

Strong Rebound Stocks: Tiandi Online (rebounded after volume contraction and limit-down at high levels, watch for potential breakthrough of previous highs).

III. Bearish Targets (Avoid)

• Photovoltaics (Space Photovoltaics): Association statement triggered a drop of over 5%, strong negative feedback.

• High-level Themes: Some previous speculative stocks and high-level precious metal stocks, with strong cash-out willingness.

• Volume-Reduced High-Level Stocks: Remote Vision Technology’s bidding is weak and prone to cash-out; Tiandi Online has not broken previous highs, so there is significant selling pressure.

IV. Trading Strategies (Leading Bear and Bull)

Leading Stocks: Focus only on high-recognition leaders, buy on dips without chasing highs, quick in and out, hold for 1-2 days, take profit at 5%-8%, stop loss at the 5-day moving average (leaders) / 10-day moving average (oversold).
Avoid Bears: Steer clear of high-level volume-reduced sectors with negative feedback; before the holiday, funds tend to hedge, and high-level stocks are vulnerable to sharp declines.
Position Management: Maintain total positions at 50-60%, with 30% in leaders, 40-50% in cash, and 20% in defensive sectors (consumption, banking).

V. Tomorrow’s Outlook

• Index: Shanghai Composite to fluctuate between 4050-4100, focus on volume and northbound funds.

• Themes: Rotation among chemicals, Chinese medicine, commercial aerospace, and AI applications, with emphasis on the sustainability of leaders and rebound opportunities.

• Risks: Volatility in US stocks, pre-holiday cash-out, and caution against sharp rises followed by pullbacks in reduced volume.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.